ARTICLE | Clinical News
Seroquel quetiapine: Post-marketing study data
January 9, 2006 8:00 AM UTC
In a double-blind, German, post-marketing study in 44 schizophrenia patients with negative symptoms, 12 weeks treatment with Seroquel or Risperdal both significantly improved the PANSS total, positiv...